SCHEMBL10066226

SCHEMBL10066226

CN[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 2/20 0.58
▸ PKM P14618 2/20 0.54
▸ FOLH1 Q04609 6/20 0.53
▸ PRSS1 P07477 2/20 0.52
▸ PRSS2 P07478 2/20 0.52
▸ PRSS3 P35030 2/20 0.52
▸ TPSAB1 Q15661 2/20 0.52
▸ F2 P00734 1/20 0.52
▸ PSEN1 P49768 3/20 0.49
▸ PSEN2 P49810 3/20 0.49
▸ APH1B Q8WW43 3/20 0.49
▸ NCSTN Q92542 3/20 0.49
▸ APH1A Q96BI3 3/20 0.49
▸ PSENEN Q9NZ42 3/20 0.49
▸ HSP90AB1 P08238 1/20 0.48
▸ PLG P00747 1/20 0.47
▸ CNR1 P21554 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ EGLN1 Q9GZT9 1/20 0.46
▸ KDM2A Q9Y2K7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12984158 0.92 CAPN1 (0.56) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL10065714 0.86 PRSS1 (0.50) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL12985194 0.81 FOLH1 (0.63) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL8106640 0.81 FOLH1 (0.54) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL8115912 0.81 FOLH1 (0.61) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL23879992 0.80 F2 (0.67) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL19229658 0.80 PKM (0.70) PKMFOLH1PRSS1PRSS2PRSS3
SCHEMBL10066225 0.80 FOLH1 (0.61) CAPN1PKMFOLH1PRSS1PRSS2
SCHEMBL17171624 0.79 PKM (0.68) PKMFOLH1PRSS1PRSS2PRSS3
SCHEMBL17126770 0.78 F2 (0.67) CAPN1PKMFOLH1PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165211-A1 Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques BRACCO IMAGING S.P.A. (IT) 2012-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165211-A1 Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques TAGLN2, TTN, TXLNA CAPN1 2006/4885PKM 2923/4885FOLH1 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback